About BioSapien
BioSapien is a company based in New York (United States) founded in 2018. BioSapien has raised $10.6 million across 6 funding rounds from investors including Hikma, MicroVentures and JPIN. The company has 1 employees as of March 21, 2024. BioSapien offers products and services including MediChip™. BioSapien operates in a competitive market with competitors including Basilisk and Mimicrete, among others.
- Headquarter New York, United States
- Employees 1 as on 21 Mar, 2024
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosapien India Private Limited
- Date of Incorporation 28 Jun, 2021
- Jurisdiction Gudivada, Andhra Pradesh, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.6 M (USD)
in 6 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Jul 08, 2025
-
Investors
Hikma
& 11 more
-
Employee Count
1
as on Mar 21, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioSapien
BioSapien offers a comprehensive portfolio of products and services, including MediChip™.
Delivers targeted drugs to tumors, reducing side effects and aiding surgery.
People of BioSapien
Unlock access to complete
Unlock access to complete
Funding Insights of BioSapien
BioSapien has successfully raised a total of $10.6M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $1.8M
-
First Round
First Round
(01 May 2021)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Seed - BioSapien | Valuation | SOSV | |
| Jan, 2025 | Amount | Seed - BioSapien | Valuation |
investors |
|
| Dec, 2024 | Amount | Seed - BioSapien | Valuation | Global Ventures |
Investors in BioSapien
BioSapien has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hikma, MicroVentures and JPIN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in Southeast Asian startups
|
Founded Year | Domain | Location | |
|
Investments are directed toward growth-stage tech firms in emerging markets.
|
Founded Year | Domain | Location | |
|
Multi sector focused full-service investment banking firm also offering VC investments
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioSapien
Financial Statements - BioSapien
Biosapien Comparisons
Frequently Asked Questions about BioSapien
BioSapien was founded in 2018 and raised its 1st funding round 3 years after it was founded.
BioSapien is headquartered in New York, United States. It is registered at New York, New York, United States.
BioSapien is a funded company, having raised a total of $10.6M across 6 funding rounds to date. The company's 1st funding round was a Seed of $5.5M, raised on May 01, 2021.
As of Mar 21, 2024, the latest employee count at BioSapien is 1.
BioSapien developer of 3d-printed chip for cancer indications, focusing on high tech, nanotechnology, nanoenabled products, life science, drug delivery, encapsulation, and cancer treatment. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
BioSapien offers MediChip™.
BioSapien has 12 investors. Key investors include Hikma, MicroVentures, JPIN, Golden Gate Ventures, and Global Ventures.